{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:09:56Z","timestamp":1768338596634,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10067-021-06004-y","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T06:02:41Z","timestamp":1638165761000},"page":"1177-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Coronavirus disease 2019 in patients with Behcet\u2019s disease: a report of 59 cases in Iran"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-6203","authenticated-orcid":false,"given":"Farhad","family":"Shahram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9675-5237","authenticated-orcid":false,"given":"Kamal","family":"Esalatmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-6967","authenticated-orcid":false,"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8731-7999","authenticated-orcid":false,"given":"Zahra","family":"Rezaieyazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Mirfeizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-4790","authenticated-orcid":false,"given":"Alireza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Soroosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4762-6943","authenticated-orcid":false,"given":"Hoda","family":"Kavosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-1306","authenticated-orcid":false,"given":"Shayan","family":"Mostafaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"6004_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","volume":"52","author":"C Pollard","year":"2020","unstructured":"Pollard C, Morran M, Nestor-Kalinoski A (2020) The COVID-19 pandemic: a global health crisis. Physiol Genomics 52:549\u2013557","journal-title":"Physiol Genomics"},{"key":"6004_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11239-020-02289-z","volume":"51","author":"A Eslambolchi","year":"2021","unstructured":"Eslambolchi A, Aghaghazvini L, Gholamrezanezhad A et al (2021) Coronavirus disease 2019 (COVID-19) in patients with systemic autoimmune diseases or vasculitis: radiologic presentation. J Thromb Thrombolys 51:339\u2013348","journal-title":"J Thromb Thrombolys"},{"key":"6004_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217615","author":"E Favalli","year":"2021","unstructured":"Favalli E, Ingegnoli F, Cimaz R et al (2021) What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217615","journal-title":"Ann Rheum Dis"},{"key":"6004_CR4","doi-asserted-by":"publisher","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC\u00a0(2020) COVID-19 Global rheumatology alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis 79(7):859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","DOI":"10.1136\/annrheumdis-2020-217871"},{"key":"6004_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","volume":"79","author":"J Pablos","year":"2020","unstructured":"Pablos J, Abasolo L, Alvaro-Gracia J et al (2020) Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis 79:1170\u20131173","journal-title":"Ann Rheum Dis"},{"key":"6004_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","volume":"50","author":"X Michelena","year":"2020","unstructured":"Michelena X, Borrell H, Lopez-Corbeto M et al (2020) Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum 50:564\u2013570","journal-title":"Semin Arthritis Rheum"},{"key":"6004_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/annrheumdis-2020-217322","volume":"79","author":"G Figueroa-Parra","year":"2020","unstructured":"Figueroa-Parra G, Aguirre-Garcia G, Gamboa-Alonso C et al (2020) Are my patients with rheumatic diseases at higher risk of COVID-19? Ann Rheum Dis 79:839\u2013840","journal-title":"Ann Rheum Dis"},{"key":"6004_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/jcm10040605","volume":"10","author":"T Welzel","year":"2021","unstructured":"Welzel T, Samba S, Klein R et al (2021) COVID-19 in autoinflammatory diseases with immunosuppressive treatment. J Clin Med 10:605","journal-title":"J Clin Med"},{"key":"6004_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","volume":"80","author":"S Akiyama","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D et al (2021) Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis 80:384\u2013391","journal-title":"Ann Rheum Dis"},{"key":"6004_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/annrheumdis-2020-217888","volume":"79","author":"K D\u2019Silva","year":"2020","unstructured":"D\u2019Silva K, Serling-Boyd N, Wallwork R et al (2020) Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u2018hot spot.\u2019 Ann Rheum Dis 79:1156\u20131162","journal-title":"Ann Rheum Dis"},{"key":"6004_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217681","volume":"80","author":"E Conticini","year":"2021","unstructured":"Conticini E, Bargagli E, Bardelli M et al (2021) COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Ann Rheum Dis 80:e14. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217681","journal-title":"Ann Rheum Dis"},{"key":"6004_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218756","author":"A Khabbazi","year":"2020","unstructured":"Khabbazi A, Kavandi H, Paribanaem R et al (2020) Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218756","journal-title":"Ann Rheum Dis"},{"key":"6004_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha A, Lu Q (2021) COVID-19 and autoimmune diseases. Curr Opin Rheumatol 33:155\u2013162","journal-title":"Curr Opin Rheumatol"},{"key":"6004_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/1756-185X.13959","volume":"23","author":"L Hassen","year":"2020","unstructured":"Hassen L, Almaghlouth I, Hassen I et al (2020) Impact of COVID-19 outbreak on rheumatic patients\u2019 perceptions and behaviors: a cross-sectional study. Int J Rheum Dis 23:1541\u20131549","journal-title":"Int J Rheum Dis"},{"key":"6004_CR15","first-page":"233","volume":"43","author":"F Davatchi","year":"2005","unstructured":"Davatchi F, Shahram F, Chams C et al (2005) Beh\u00e7et\u2019s disease. Acta Med. Iran 43:233\u2013242","journal-title":"Iran"},{"key":"6004_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"J Jennette","year":"2013","unstructured":"Jennette J, Falk R, Bacon P et al (2013) 2012 revised international Chapel Hill consensusconference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"6004_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17325","author":"C Zouboulis","year":"2021","unstructured":"Zouboulis C, van Laar J, Schirmer M et al (2021) Adamantiades-Behcet\u2019s disease (Behcet\u2019s disease) and COVID-19. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.17325","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6004_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"F Davatchi","year":"2014","unstructured":"Davatchi F, Assaad-Khalil S, Calamia K et al (2014) The international criteria for Beh\u00e7et\u2019s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specifcity of the new criteria. J Eur Acad Dermatol Venereol 28:338\u2013347","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6004_CR19","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"6004_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02427-8","author":"B Yurtta\u015f","year":"2020","unstructured":"Yurtta\u015f B, Oztas M, Tunc A et al (2020) Characteristics and outcomes of Beh\u00e7et\u2019s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients. Intern Emerg Med. https:\/\/doi.org\/10.1007\/s11739-020-02427-8","journal-title":"Intern Emerg Med"},{"key":"6004_CR21","unstructured":"Johns Hopkins University CSSE (2021) Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/region\/iran, Accessed 21 March 2021."},{"key":"6004_CR22","unstructured":"WHO COVID-19 Dashboard (2021) https:\/\/covid19.who.int\/region\/emro\/country\/ir, Accessed 21 March 2021."},{"key":"6004_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14397595.2018.1558752","volume":"29","author":"F Davatchi","year":"2019","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C et al (2019) Behcet\u2019s disease in Iran; Analysis of 7641 cases. Mod Rheumatol 29:1023\u20131030","journal-title":"Mod Rheumatol"},{"key":"6004_CR24","doi-asserted-by":"crossref","unstructured":"Mattioli I, Bettiol A, Silvestri E, Urban ML, Palermo A, Fagni F, Malandrino D, Del Bianco A, Prisco D, Emmi G\u00a0(2021) Prevalence and clinical course of SARS-CoV-2 infection in patients with Beh\u00e7et's syndrome. Clin Exp Rheumatol 39 Suppl\u00a0 132(5):47\u201350","DOI":"10.55563\/clinexprheumatol\/pmnqmf"},{"key":"6004_CR25","first-page":"e14063","volume":"33","author":"R Dursun","year":"2020","unstructured":"Dursun R, Temiz S, Ozer I et al (2020) Management of patients with Behcet\u2019s disease during the COVID-19 pandemic. Dermatol Ther 33:e14063","journal-title":"Dermatol Ther"},{"key":"6004_CR26","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","volume":"383","author":"R Gandhi","year":"2020","unstructured":"Gandhi R, Lynch J, Del Rio C (2020) Mild or moderate Covid-19. N Engl J Med 383:1757\u20131766","journal-title":"N Engl J Med"},{"key":"6004_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217778","author":"G Espinosa","year":"2020","unstructured":"Espinosa G, Araujo O, Amaro S et al (2020) COVID-19 and Beh\u00e7et\u2019s disease: clinical case series. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217778","journal-title":"Ann Rheum Dis"},{"key":"6004_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/annrheumdis-2020-217627","volume":"79","author":"C Ye","year":"2020","unstructured":"Ye C, Cai S, Shen G et al (2020) Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann Rheum Dis 79:1007\u20131013","journal-title":"Ann Rheum Dis"},{"key":"6004_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218171","author":"C Brito","year":"2020","unstructured":"Brito C, Paiva J, Pimentel F et al (2020) COVID-19 in patients with rheumatological diseases treated with anti-TNF. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218171","journal-title":"Ann Rheum Dis"},{"key":"6004_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinpr.2020.100041","author":"C Jensen","year":"2020","unstructured":"Jensen C, Wilson S, Thombare A et al (2020) Cold agglutinin syndrome as a complication of Covid-19 in two cases. Clin Infect Pract. https:\/\/doi.org\/10.1016\/j.clinpr.2020.100041","journal-title":"Clin Infect Pract"},{"key":"6004_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2020.06.005","author":"N Patil","year":"2020","unstructured":"Patil N, Herc E, Girgis M (2020) Cold agglutinin disease and autoimmune haemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol Oncol Stem Cell Ther. https:\/\/doi.org\/10.1016\/j.hemonc.2020.06.005","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"6004_CR32","first-page":"9695","volume":"24","author":"R Bonometti","year":"2020","unstructured":"Bonometti R, Sacchi M, Stobbione P et al (2020) The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci 24:9695\u20139697","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6004_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219279","author":"N Serling-Boyd","year":"2020","unstructured":"Serling-Boyd N, D\u2019Silva K, Hsu T et al (2020) Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219279","journal-title":"Ann Rheum Dis"},{"key":"6004_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/annrheumdis-2020-218310","volume":"80","author":"FAI2R, SFR, SNFMI, SOFREMIP, CRI, IMIDIATE consortium and contributors","year":"2020","unstructured":"FAI2R, SFR, SNFMI, SOFREMIP, CRI, IMIDIATE consortium and contributors (2020) Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients. Ann Rheum Dis 80:527\u2013538","journal-title":"Ann Rheum Dis"},{"key":"6004_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","volume":"383","author":"R Haberman","year":"2020","unstructured":"Haberman R, Axelrad J, Chen A et al (2020) Covid-19 in immune-mediated inflammatory diseases - case series from New York. N Engl J Med 383:85\u201388","journal-title":"N Engl J Med"},{"key":"6004_CR36","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.41456","volume":"72","author":"R Haberman","year":"2020","unstructured":"Haberman R, Castillo R, Chen A et al (2020) COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes. Arthritis Rheumatol 72:1981\u20131989","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06004-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-06004-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06004-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T15:48:27Z","timestamp":1673884107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-06004-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6004"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-06004-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Research Committee of Rheumatology Research Center and the Ethics Committee of Tehran University of Medical Sciences. The study was conducted in accordance with the Code of Ethics of the World Medical Association (Helsinki Declaration of 1975\/83) for experiments involving humans and Good Clinical Practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A written informed consent was obtained from each participant according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the final version to be published and agreed to be accountable for all aspects of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}